|
Chemical
companies eye pharma pastures
Over the past few years, there has been a gradual increase
in the number of traditional chemical companies making a foray
into the pharmaceutical sector in order to give impetus to
their growth plans and make robust profits.By Sapna Dogra.
Upfront
Ranbaxy’s
treasure hunt
After a slow year, Ranbaxy is all set to strike gold with
new drugs in the pipeline and a future course of action called
'Vision Garuda'. Sapna Dogra discovers, in conversation with
Brian Tempest.
Glenmark
eyes the US generic market
Glenmark Pharmaceuticals and InvaGen Pharma-ceuticals have
entered into a collaboration deal for the joint development,
filing and marketing of seven generic pharmaceutical products
for the US market.
Wockhardt
launches new generation Hepatitis A vaccine
Wockhardt has launched a new generation Hepatitis A vaccine
under the brand name of Biovac A, in collaboration with Zhejiang
Vaccine.
Zydus
Cadila and Bharat Serums set up JVC
Zydus Cadila and Bharat Serums and Vaccines (BSV), one of
the top ten Biotech companies in India, have signed an agreement
to set up a 50:50 joint venture company.
SPI
Pharma launches India operations
SPI Pharma, a fully owned subsidiary of Associated British
Foods company and a worldwide leader in custom formulation
solutions for pharmaceutical manufacturers, has commissioned
a full-fledged drug development and testing centre in Bangalore.
The facility was inaugurated by Dr Venkateswarlu, Deputy Drugs
Controller of India.
Better
than sugar
'Pharma
industry is the lifeline of the country'
IDMA turned 44 this year and the celebrations included a recollection
of the pharma events in 2005 and the proposals on the new
drug policy, Deepali Gupta reports.
Stock
Watch
|
